Page last updated: 2024-10-26

valproic acid and As If Personality

valproic acid has been researched along with As If Personality in 12 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
" The anticonvulsants valproate and topiramate appeared to have the most empirical support for having a favorable effect on symptoms of borderline personality disorder."4.85[Empirical evidence for the use of anticonvulsants in personality disorders]. ( Emrich, HM; Sieberer, M, 2009)
"This 12-month, prospective, observational study investigated factors associated with symptomatic remission (total YMRS score < or =12) and full clinical recovery (sustained reduction in CGI-BP-S overall score) in bipolar disorder during treatment with atypical antipsychotics (predominantly olanzapine, risperidone and quetiapine; alone or in combination with a psychotropic such as lithium or valproate) in actual clinical practice."3.76Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics. ( Badr, MG; D'yachkova, Y; Dikeos, D; Fábián, Z; Harrison, G; Hudiţă, C; Okasha, T; Pesek, MB; Tapia-Paniagua, G; Treuer, T; Yang, F, 2010)
"An experimental and clinico-pharmacological study of sodium valproate, a GABA-ergic drug, was conducted to elucidate the role of gamma-aminobutyric acid in the mechanisms responsible for affective disturbances, in particular for anxiety."3.67[Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)]. ( Aleksandrovskiĭ, IuA; Kharlamov, AN; Neznamov, GG; Poiurovskiĭ, MV; Raevskiĭ, KS, 1985)
"Fifty-two outpatients with DSM-IV borderline personality disorder were randomly assigned to receive divalproex (N=20) or placebo (N=32), double-blind, for 12 weeks."2.71Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. ( Coccaro, EF; Hollander, E; Jiang, P; Smith, TB; Swann, AC, 2005)
" Divalproex sodium was increased as tolerated using a flexible dosing schedule."2.69Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. ( Coccaro, EF; Kavoussi, RJ, 1998)
"Early treatment of epilepsy is warranted to avoid possible severe consequences."1.39Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle. ( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's2 (16.67)18.2507
2000's5 (41.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rapinesi, C1
Del Casale, A1
Serata, D1
Kotzalidis, GD2
Scatena, P1
Muzi, A1
Lazanio, S1
Savoja, V2
Carbonetti, P1
Fensore, C1
Ferracuti, S2
Angeletti, G2
Tatarelli, R2
Girardi, P2
Sieberer, M1
Emrich, HM1
Dikeos, D1
Badr, MG1
Yang, F1
Pesek, MB1
Fábián, Z1
Tapia-Paniagua, G1
Hudiţă, C1
Okasha, T1
D'yachkova, Y1
Harrison, G1
Treuer, T1
Sani, G1
De Rossi, P1
Stefani, S1
Pancheri, L1
Santucci, C1
Roma, P1
Simonetti, A1
Ambrosi, E1
Comparelli, A1
Manfredi, G1
Hollander, E2
Tracy, KA1
Swann, AC2
Coccaro, EF3
McElroy, SL1
Wozniak, P1
Sommerville, KW1
Nemeroff, CB1
Barkai, G1
Goshen, E1
Tzila Zwas, S1
Dolberg, OT1
Pick, CG1
Bonne, O1
Schreiber, S1
Jiang, P1
Smith, TB1
Yatham, LN1
Kennedy, SH1
O'Donovan, C1
Parikh, S1
MacQueen, G1
McIntyre, R1
Sharma, V1
Silverstone, P1
Alda, M1
Baruch, P1
Beaulieu, S1
Daigneault, A1
Milev, R1
Young, LT1
Ravindran, A1
Schaffer, A1
Connolly, M1
Gorman, CP1
Deltito, JA1
Kavoussi, RJ1
Deisenhammer, E1
Raevskiĭ, KS1
Aleksandrovskiĭ, IuA1
Poiurovskiĭ, MV1
Kharlamov, AN1
Neznamov, GG1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Double-blind, Double-dummy, Controlled Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide - a Pilot Study[NCT00400088]Phase 32 participants (Actual)Interventional2007-06-30Terminated (stopped due to Recruitment difficulties)
Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression: Double-Blind, Placebo-Controlled Study to Establish Efficacy and Safety[NCT00590265]50 participants (Anticipated)Interventional2008-01-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for valproic acid and As If Personality

ArticleYear
[Empirical evidence for the use of anticonvulsants in personality disorders].
    Fortschritte der Neurologie-Psychiatrie, 2009, Volume: 77, Issue:3

    Topics: Amines; Anticonvulsants; Borderline Personality Disorder; Carbamazepine; Cyclohexanecarboxylic Acids

2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Bipolar disorders, 2005, Volume: 7 Suppl 3

    Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Benzodiaz

2005
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Bipolar disorders, 2005, Volume: 7 Suppl 3

    Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Benzodiaz

2005
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Bipolar disorders, 2005, Volume: 7 Suppl 3

    Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Benzodiaz

2005
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Bipolar disorders, 2005, Volume: 7 Suppl 3

    Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Benzodiaz

2005

Trials

4 trials available for valproic acid and As If Personality

ArticleYear
Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:6

    Topics: Adult; Aged; Aggression; Analysis of Variance; Chi-Square Distribution; Double-Blind Method; Female;

2003
Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    The American journal of psychiatry, 2005, Volume: 162, Issue:3

    Topics: Adult; Age of Onset; Aggression; Anticonvulsants; Borderline Personality Disorder; Double-Blind Meth

2005
Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12

    Topics: Adult; Aggression; Anticonvulsants; Antimanic Agents; Female; Fluoxetine; Humans; Impulsive Behavior

1998
[Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Wiener medizinische Wochenschrift (1946), 1977, Jun-20, Volume: 127, Issue:12

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Epi

1977

Other Studies

6 other studies available for valproic acid and As If Personality

ArticleYear
Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle.
    Brain injury, 2013, Volume: 27, Issue:7-8

    Topics: Accidents, Traffic; Aggression; Amines; Anterior Temporal Lobectomy; Anticonvulsants; Brain Injuries

2013
Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:4

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statisti

2010
Bipolar disorder presenting as stalking--a case report.
    Psychiatria Danubina, 2011, Volume: 23, Issue:1

    Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality

2011
Acetazolamide-enhanced neuroSPECT scan reveals functional impairment after minimal traumatic brain injury not otherwise discernible.
    Psychiatry research, 2004, Dec-30, Volume: 132, Issue:3

    Topics: Acetazolamide; Adult; Brain; Brain Injuries; Carbonic Anhydrase Inhibitors; Cognition Disorders; Hum

2004
The effect of valproate on bipolar spectrum temperamental disorders.
    The Journal of clinical psychiatry, 1993, Volume: 54, Issue:8

    Topics: Adult; Bipolar Disorder; Cyclothymic Disorder; Female; Humans; Male; Middle Aged; Personality Disord

1993
[Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1985, Volume: 85, Issue:4

    Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety; Brain; Cats; Female; gamma-Aminobutyric Acid; Humans;

1985